JP Morgan Chase
IART icon

JP Morgan Chase’s Integra LifeSciences IART Stock Holding History

JP Morgan Chase’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,400
Closed -$4.7M – 5864
2019
Q1 		$4.7M Buy
+84,400
New +$4.3M ﹤0.01% 2632

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JP Morgan Chase's IART Position: Q2 2026 in Review

JP Morgan Chase reduced its Integra LifeSciences (IART) stake by 45% in Q2 2026, selling an estimated $2.49M and leaving 214,504 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

JP Morgan Chase first reported a position in IART in Q2 2013 and has held it in 50 quarters since. The position peaked at $18.3M in Q3 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • JP Morgan Chase held 214,504 shares of Integra LifeSciences worth $4.02M as of Q2 2026.
  • JP Morgan Chase sold 177,964 Integra LifeSciences shares in Q2 2026, an estimated $2.49M.
  • Integra LifeSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3634 holding.
  • JP Morgan Chase first reported a position in Integra LifeSciences in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Integra LifeSciences position peaked at $18.3M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.